Area of research
Molecular Biology · Neurology
Research interest
Research interests include Ubiquitin and proteasome pathways, Neuroblastoma Research and Treatments, Lymphoma Diagnosis and Treatment, and Acute Lymphoblastic Leukemia research.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Excellent outcomes in children and adolescents with <scp>CNS</scp><sup>+</sup> Burkitt lymphoma or other mature B‐<scp>NHL</scp> using only intrathecal and systemic chemoimmunotherapy: results from <scp>FAB</scp>/<scp>LMB</scp>96 and <scp>COG ANHL</scp>01P1
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive <scp>B</scp>urkitt lymphoma/leukaemia: a Children's Oncology Group Report
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature <scp>B</scp>‐<scp>NHL</scp>: a <scp>C</scp>hildren's <scp>O</scp>ncology <scp>G</scp>roup <scp>R</scp>eport